Bengaluru: Karnataka is fully prepared for the distribution of COVID-19 vaccine, Health and Medical Education Minister K Sudhakar said on Wednesday, as phase-III clinical trial of “Covaxin” being developed by Bharat Biotech began in the state. The minister said it was a matter of pride for the state with clinical trials taking place at 25 centres of 12 states across the […]
Read MoreNew Delhi: Vaccine major Serum Institute of India (SII) on Saturday said it is in the process of applying for an emergency use licensure for the AstraZeneca-Oxford’s COVID-19 vaccine candidate in India in the next two weeks. Addressing a virtual press conference on the visit of Prime Minister Narendra Modi to the company’s Pune facility, Serum Institute […]
Read MoreBhubaneswar: The third phase human trial of Covaxin, the much-awaited indigenously developed Covid-19 vaccine, has begun at an institute here, a senior official said on Friday. The vaccine was administered to two recruits on Thursday at the Preventive and Therapeutic Clinical Trial Unit (PTCTU) at the Institute of Medical Sciences and SUM Hospital, the only […]
Read MoreChandigarh: Haryana Health Minister Anil Vij who had offered to be the first volunteer in the phase three trials for Covaxin, a potential vaccine against COVID-19, will get the dose on Friday. The 67-year old senior Bharatiya Janata Party leader said he will be administered the trial dose of the indigenous vaccine at the Civil Hospital at Ambala […]
Read MoreGorakhpur: The human clinical trial of indigenously developed Covaxin, a possible vaccine against coronavirus, began at a hospital here, officials said on Friday. The trial began on Thursday evening at Rana Hospital and Trauma Centre, which is among the 12 institutes selected for clinical trials of the vaccine, officials said here. “The trials began under […]
Read More